Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · IEX Real-Time Price · USD
3.570
+0.050 (1.42%)
Jul 22, 2024, 10:49 AM EDT - Market open
Adlai Nortye Employees
Adlai Nortye had 127 employees as of December 31, 2023. The number of employees decreased by 2 or -1.55% compared to the previous year.
Employees
127
Change (1Y)
-2
Growth (1Y)
-1.55%
Revenue / Employee
$39,370
Profits / Employee
-$825,756
Market Cap
57.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 127 | -2 | -1.55% |
| Dec 31, 2022 | 129 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Rockwell Medical | 237 |
| Neuronetics | 203 |
| Enzo Biochem | 190 |
| Cytosorbents | 186 |
| LENSAR | 130 |
| Mural Oncology | 117 |
| VolitionRx | 110 |
| CollPlant Biotechnologies | 75 |
ANL News
- 2 months ago - Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024 - GlobeNewsWire
- 2 months ago - Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy - GlobeNewsWire
- 4 months ago - Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development - GlobeNewsWire
- 8 months ago - Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC - GlobeNewsWire
- 9 months ago - Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award - GlobeNewsWire
- 10 months ago - Adlai Nortye Ltd. Announces Closing of Initial Public Offering - GlobeNewsWire
- 10 months ago - Adlai Nortye Ltd. Announces Pricing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Cancer treatment company Adlai Nortye sets terms in IPO - Market Watch